Rifaquizinone

Overview

Rifaquizinone (CBR-2092) is a Rifamycin-Quinolone Hybrid Antibiotic . Rifaquizinone inhibits wild-type S. aureus RNA polymerase with an IC 50 of 34 nM. Rifaquizinone is effective against S. aureus infections, with MICs ranged from 0.008 to 0.5 μg/mL for 300 clinical isolates of staphylococci and streptococci .

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-135184
• CAS No.: 922717-97-3
• Molecular Formula: C65H81FN6O15
• Molecular Weight: 1205.37
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source